Meloxicam Almus

Meloxicam, the active ingredient in Meloxicam Almus, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for systemic use. It is indicated for the management of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute musculoskeletal pain in adult patients.

GNH USA supplies Meloxicam Almus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets. All shipments are accompanied by full documentation to facilitate import compliance.

Meloxicam is an NSAID that reduces inflammation and pain in several musculoskeletal disorders. - Osteoarthritis: alleviates joint pain and stiffness, improving function. - Rheumatoid arthritis: decreases synovial inflammation and pain, helping preserve joint mobility. - Ankylosing spondylitis: relieves spinal pain and reduces inflammatory markers. - Acute pain: provides short‑term relief of moderate to severe pain from injuries or postoperative states.

Like other NSAIDs, meloxicam may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal discomfort or dyspepsia. - Headache. - Dizziness or light‑headedness. - Peripheral edema.

Serious or Rare Side Effects: - Peptic ulcer bleeding or perforation. - Severe skin reactions such as Stevens‑Johnson syndrome. - Acute renal impairment or failure, especially in patients with pre‑existing kidney disease.

Before initiating meloxicam therapy, several safety considerations should be observed. - Assess renal function: evaluate kidney health prior to treatment. - Monitor hepatic enzymes: check liver function periodically during use. - Use lowest effective dose: limit exposure to reduce cardiovascular and gastrointestinal risks. - Avoid in patients with known hypersensitivity to NSAIDs: discontinue immediately if allergic signs appear. - Caution in elderly: increased susceptibility to gastrointestinal bleeding and renal adverse events. - Store at ambient temperature: keep in original container, protect from moisture and light.

Meloxicam can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened bleeding risk. - Lithium: increased serum lithium concentrations. - Methotrexate: enhanced toxicity. - ACE inhibitors or ARBs: possible reduction in renal function. - SSRIs or SNRIs: increased gastrointestinal bleeding potential.

Moderate Interactions (Monitor Closely): - Diuretics: may exacerbate renal impairment. - Beta‑blockers: potential attenuation of antihypertensive effect. - Concomitant NSAIDs: additive gastrointestinal toxicity. - CYP2C9 inhibitors (e.g., fluconazole): may raise meloxicam plasma levels. - Allopurinol: risk of hypersensitivity reactions.